lilly new glp 1 launches GLP-1 pill, kicking off showdown with Novo Nordisk RO OFFERS ELI LILLY'S FOUNDAYO™,
Description
doi: 10.2174/1573399811309020007
however, some data suggest that it may lead to modest reductions in weight
The negative reviews describe no weight change at all, skin rashes, redness and irritation at the application site, and in some cases blisters and burns
Short-term, low-dose steroids may cause minimal disruption, while chronic high-dose use significantly blunts GLP-1 efficacy
